Tariff impacts on biotech are 'company-by-company specific'
Salveen Richter, Goldman Sachs lead US biotech analyst for global investment research, joins Market Domination with Josh ...
Apellis Pharmaceuticals (APLS) Gets a Hold from Mizuho Securities
In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research ...
Summit Therapeutics Inc. (SMMT): Why Are Analysts Bullish On This Hot Growth Stock Right Now?
We recently compiled a list of the 10 Hot Growth Stocks to Invest in According to Analysts. In this article, we are going to ...
Breaking Down Apellis Pharmaceuticals: 6 Analysts Share Their Views
In the assessment of 12-month price targets, analysts unveil insights for Apellis Pharmaceuticals, presenting an average ...
Nasdaq5d
Breaking Down Apellis Pharmaceuticals: 6 Analysts Share Their Views
Analysts' ratings for Apellis Pharmaceuticals (NASDAQ:APLS) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below ...